Anti-PD-1 antibodies, antigen-binding portions thereof and checkpoint regulator antogonists comprising the same

Antibodies specific for IL-21 and uses thereof

Endoglin peptides to treat fibrotic diseases

METHODS AND COMPOSITIONS FOR LIGAND DIRECTED ANTIBODY DESIGN

Express humanization of antibodies

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy

Methods for treating conditions associated with MASP-2 dependent complement activation

Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome

Anti-ALK antibodies and methods for use thereof

Antagonistic CD40 monoclonal antibodies and uses thereof

Anti-BCMA heavy chain-only antibodies

Anti-PD-L1 antibodies and uses thereof

CTLA4 binders

Anti-PD-1 antibodies and methods of making and using thereof

Anti-CEACAM6 antibodies and uses thereof

Anti-ROBO2 antibodies, compositions, methods and uses thereof

Anti-IL-22R antibodies

Anti-C5 antibodies having improved pharmacokinetics

Human antibodies to GREM1

Anti-antibodies and uses thereof

Modular self assembly disassembly (SADA) technologies

Lysine monomethylated derivative and corresponding antibody and use thereof

Glycosylation of variable immunoglobulin domains

Bispecific antibodies for factor IX and factor X

Anti-CD73 monoclonal antibody, encoding nucleic acids and method for producing

MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH

CANCER-ASSOCIATED IMMUNOSUPPRESSION INHIBITOR

SUBTYPES OF HUMANIZED ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR

Anti-CLL-1 antibodies and methods of use

Inducible monovalent antigen binding protein

Anti-PVRIG antibodies and methods of use

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

Anti-CD33 antibodies and uses thereof

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE

USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE

Methods of Treating Inflammatory Pain

Human antibodies to Ebola virus glycoprotein

Ebola Virus Antibodies and Binding Agents Derived Therefrom

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate

ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES

DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES

Multivalent glycopeptides that tightly bind to target proteins

INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES

Biparatopic and multiparatopic antibodies with common light chain and method of use

CD6 antibody for treatment of T-cell mediated diseases or disorders

Hyperglycosylated binding polypeptides

Anti-OX40 antibody and use thereof

Anti-PD-L1 antibodies

Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection

ICOS BINDING PROTEINS

ANTIGEN BINDING CONSTRUCTS TO CD8

Anti-TREM2 antibodies and related methods

TREM2 stabilizing antibodies

Anti-claudin-2 monoclonal antibody

Antibodies that bind cell surface GRP78

Anti-human interleukin-2 antibodies and uses thereof

AGGRECAN BINDING IMMUNOGLOBULINS

Anti-lap antibody variants

Nucleic acids encoding broadly neutralizing glycan-dependent 8ANC195 antibody variants that bind to an epitope spanning both HIV-1 ENV subunits

Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof

Light chain variable regions

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Anti-IL-23 antibodies, compositions, methods and uses

Humanized antibodies

Compositions and methods of cellular immunotherapy

Therapeutic molecules binding PSMA

ANTIBODIES TO OPGL

NKp46 binding proteins

TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo

Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1

Anti-TREM1 antibodies and methods of use thereof

Angiopoietin 2, VEGF dual antagonists

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

Anti-PACAP antibody

Analysis of ubiquitinated polypeptides

Compositions and methods for treating and preventing infections

IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

Cysteine modified antibody-drug conjugate and preparation method thereof

ANTIBODY DRUG CONJUGATES

COMPUTATIONAL AFFINITY MATURATION OF ANTIBODY LIBRARIES USING SEQUENCE ENUMERATION

Antibody identification by lineage analysis

Heterodimeric Fc variants

Chimeric antibody immune effector cell engagers and methods of use thereof

Anti-transferrin receptor antibodies and methods of use

Antibodies targeting b-cell maturation antigen and methods of use

Antigen-binding proteins that antagonize leptin receptor

Anti-NPR1 antibodies and uses thereof

BISPECIFIC ANTIBODIES

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments

ICOS binding proteins

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Antibody for treating autoimmune diseases

Bispecific antibodies against CEACAM5 and CD47

Nucleic acid molecules encoding anti-GPRC5D antibodies

METHODS OF TREATING CANCERS USING ANTI-GPRC5D ANTIBODIES

Heavy chain only antibodies to PDGF

Tau immunotherapy

Multispecific antibodies targeting human immunodeficiency virus and methods of using the same

Agents for influenza neutralization

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

Fibronectin binding domains with reduced immunogenicity

Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies

ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Semi-synthetic nurse shark VNAR libraries for making and using selective binding compounds

T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA

Compositions and methods for treatment of diabetic macular edema

FACTOR XI ANTIBODIES AND METHODS OF USE

ANTIBODIES, BINDING FRAGMENTS, AND METHODS OF USE

Methods and antibody compositions for tumor treatment

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Anti-factor D antibody variant conjugates and uses thereof

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES

Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies

Anti-PD-1 antibodies and uses thereof

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof

Anti-CD3 antibodies

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

ANTIGEN-BINDING MOLECULE INDUCING IMMUNE RESPONSE TO TARGET ANTIGEN

Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody

METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN

Methods of detecting plasma kallikrein

PD-L1 antibodies binding canine PD-L1

BCMA binding molecules and methods of use thereof

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

NK cell engaging antibody fusion constructs

Antibody binding to FCRN for treating autoimmune diseases

Anti-CD79 antibodies and their uses

Anti-CEACAM1 antibody and use thereof

COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS BY NK CELLS

Anti-TMEFF1 antibodies and antibody drug conjugates

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Antibodies directed against leukotoxins

Combinations of anti-antibodies

Neutralizing anti-influenza A antibodies and uses thereof

Neutralizing anti-influenza binding molecules and uses thereof

Anti-pre-S1 HBV antibodies

Directed evolution of multivalent glycopeptides that tightly bind to target proteins

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Anti-CEACAM5 antibodies and uses thereof

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody

Anti-CXCR4 antibodies and antibody-drug conjugates

ASPGR antibodies and uses thereof

ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF

Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies

Antibodies specific to delta 1 chain of T cell receptor

SIRP-α binding proteins and methods of use thereof

Modified variable domain molecules and methods for producing them

SCFV'S FOR LIVE CELL IMAGING AND OTHER USES

COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

Immunoparticles and methods of generating and using same

Antigen-specific tolerance and compositions for induction of same

Anti-TIGIT antigen-binding proteins and methods of uses thereof

DLL3 binding proteins and methods of use

Lincosamides universal monoclonal antibody hybridoma cell strain and application thereof

Antibodies for the prevention or the treatment of bleeding episodes

Antibodies to coagulation factor XIa and uses thereof

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

Anti-IL1RAP antibodies

ANTIBODY HEAVY CHAIN VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

Therapeutic CD47 antibodies

Antibody variants transmigrating the blood-brain barrier and uses thereof

GARP-TGF-β 1 IGG antibodies

Fc-receptor binding modified asymmetric antibodies and methods of use

Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF

Engineered antibody for inhibition of fibrosis

Compositions relating to a mutant clostridium difficile toxin and methods thereof

Anti-PD-L1 antibodies

Anti-PCSK9 antibody and use thereof

Targeted chimeric proteins and uses thereof

HUMANIZED ANTI-CD40 ANTIBODIES

Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R)

ALK7 binding proteins and uses thereof

Method of screening for anti-GARP antibodies

CD200R agonist antibodies and uses thereof

Methods of treating FGF21-associated disorders

ANTIBODIES TO IL-6 AND USE THEREOF

Anti-transthyretin antibodies

METHODS OF TREATING CHRONIC PAIN

Antibody-drug conjugates and uses thereof

Methods of treating palmoplantar pustular psoriasis (PPP) using IL-17 antibody

Immunoconjugates Comprising Anti-HER2 Antibodies and Pyrrolobenzodiazepines

Binding molecules specific for CD73 and uses thereof

ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF

Anti-FAP antibodies and methods of use

Monoclonal antibodies against c-Met

Anti-CD47 monoclonal antibody and use thereof

Agonistic tumor necrosis factor (TNF) receptor binding agents

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

ANTIBODIES THAT BIND TO TL1A AND THEIR USES

Humanized antibodies which bind to human APRIL (“a proliferation-inducing ligand”)

Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy

Anti-AVB8 antibodies and compositions and uses thereof

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

PD-1/LAG3 BI-SPECIFIC ANTIBODIES, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME

Antibodies binding to ILT4

Anti-PACAP antibodies

Compounds

Anti-netrin-1 antibody

Isoform-selective TGFβ1 inhibitors and use thereof

DUAL RANGE CARDIAC TROPONIN IMMUNOASSAY DEVICES AND METHODS USING IMMUNOSENSOR AND MAGNETIC IMMUNOSENSOR

Immunomodulating transgenic plants and related methods

Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody

Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties

Targeted engineered interferon and uses thereof

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

Bispecific antibodies specific for OX40

Antibodies that bind to OX40 and their uses

Anti-human CD73 antibody

Anti-LAG-3 antibodies and uses thereof

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Anti-IL-33 antibodies and uses thereof

Antibody targeting interleukin 17A and preparation method and application thereof

IL-10 EGFR antibody fusion protein and uses thereof

ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION

Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Anti-TIGIT antibodies

TRISPECIFIC ANTIGEN BINDING PROTEINS

VARIANT TARGET BINDING AGENTS AND USES THEREOF

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

Methods of producing multispecific antibodies against CD40 and CD137

Recombinant antibodies to programmed death 1 (PD-1) and uses thereof

Anti-CD19 humanized antibody and immune effector cell targeting cd 19

Method for treating lupus by administering an anti-IL-12 antibody

Methods of treating a companion animal species comprising administering anti-IL31 antibodies

Monoclonal antibodies against alpha-synuclein fibrils

DbpA antibodies and uses thereof

Anti-Zika virus antibodies and methods of use

Antibody capable of binding to norovirus, composite, detection device and method using the same

Antibody capable of binding to norovirus, composite, detection device and method using the same

Identification of immunologically protective neo-epitopes for the treatment of cancers

Single linker FabFv antibodies and methods of producing same

Product and method for treating sarcopenia

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Antibody specifically binding to PAUF protein and use thereof

IL-23R ANTAGONISTS TO REPROGRAM INTRATUMORAL T REGULATORY CELLS INTO EFFECTOR CELLS

Methods of activating CD32b/c comprising administering an antibody that binds BDCA-2 (CD303)

Anti-MIC antibodies and methods of use

Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4)

Antibodies binding to VISTA at acidic pH

Antibody constructs for CLDN18.2 and CD3

Anti-GDF15 antibodies, compositions and methods of use

Anti-transthyretin antibodies

HUMANIZED ANTIBODY

Mast cell stabilizers for treatment of fever

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

Antibody preparation

Bivalent, bispecific binding proteins for prevention or treatment of HIV infection

Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Biological Products

Anti-OX40 antibodies and their uses

Cell injury inducing therapeutic drug for use in cancer therapy

Endoglin Antibodies

BISPECIFIC ANTIBODY AGAINST OX40 AND CTLA-4

Method of treating type I diabetes by administering a combination of a glucagon receptor antagonist and an anti-CD3 antibody

Anti-B7-H3 antibodies and diagnostic uses thereof

Fusion constructs and methods of using thereof

Anti-CD3 antibodies and uses thereof

CD3 binding antibodies

MULTISPECIFIC ANTIGEN BINDING PROTEINS

IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

DNA molecules encoding anti-IL-33 antibodies

Binding agents

Carbohydrate antibodies, pharmaceutical compositions and uses thereof

ANTIGEN-BINDING DOMAINS OF THE MONOCLONAL ANTI-COLLAGEN I ANTIBODY

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

METHOD FOR DETERMINING, PREDICTING AND TREATING CANCER

Anti-CD38 antibodies

ANTI-KLK5 ANTIBODIES AND METHODS OF USE

Antibodies and methods for making and using the same

Anti-PD-1 antibodies and their uses

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

Antibodies specific to human poliovirus receptor (PVR)

Anti-CD40 antibodies

Anti-CXCR2 antibodies and uses thereof

Human antibodies to GFRα3 and methods of making thereof

ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE

Anti-TIGIT Antibodies

Anti-CD112R compositions and methods

V-C-FC-V-C ANTIBODY

Methods of treatment using IL-23p19 monoclonal antibodies

Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

Antibody-mediated neutralization of Marburg virus

Epitope tag and method for detection and/or purification of tagged polypeptides

SCREENING METHODS

DETECTION METHODS EMPLOYING HCV CORE LIPID AND DNA BINDING DOMAIN MONOCLONAL ANTIBODIES

Methods for inducible expression of polypeptides

Method for treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A

Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies and methods of use thereof

Anti-GITR antibodies and methods of use thereof

Interferon receptor 1 antibodies and their uses